Clinical Trials Logo
  1. Home
  2. Discoid Lupus Erythematosus
  3. NCT03958955

Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.

Discoid Lupus Erythematosus Clinical Trial

Official title:
Efficacy and Safety of Twice-daily Application of Delgocitinib Cream 20 mg/g for 6 Weeks in Subjects With Active Discoid Lupus Erythematosus.

Clinical Trial Summary

This was a double-blind, multi-centre, randomised, vehicle-controlled, within-subject phase 2a trial. The trial was designed to establish the efficacy and safety of delgocitinib cream in the treatment of adult subjects with discoid lupus erythematosus (DLE).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03958955
Study type Interventional
Source LEO Pharma
Contact
Status Terminated
Phase Phase 2
Start date July 9, 2019
Completion date April 30, 2020
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT03866317 - A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus Phase 2
Completed NCT00001680 - A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus Phase 2
Recruiting NCT05591222 - Study of Daxdilimab (HZN-7734) in Patients With Moderate-to-Severe Primary Discoid Lupus Erythematosus Phase 2
Completed NCT00625521 - Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions Phase 2
Completed NCT04908280 - Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus Phase 2
Completed NCT02125695 - Pilot Tape Harvesting Study N/A
Completed NCT05362188 - Topical Nicotinamide in Treatment of DLE Early Phase 1
Completed NCT00708916 - Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients Phase 1/Phase 2
Terminated NCT03159936 - Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Early Phase 1
Completed NCT00691769 - Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
Completed NCT00608673 - Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus N/A
Recruiting NCT06261021 - Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects With Discoid Lupus Erythematosus Phase 2
Completed NCT00625157 - Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2) Phase 2